Ameriprise Financial »

Tscan Therapeutics shares owned by Ameriprise Financial

Quarter-by-quarter ownership of Tscan Therapeutics (TCRX) shares owned by Ameriprise Financial from 13F filings

Historical chart of Ameriprise Financial investment in Tscan Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Tscan Therapeutics held by Ameriprise Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tscan Therapeutics by Ameriprise Financial

Quarter filed Position value Share count Share price at filing
2026-03-31 $53k 53k 1.01

More positions owned by Ameriprise Financial

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Alphabet Inc Class A cs (GOOGL)
Broadcom (AVGO)
Amazon (AMZN)
JPMorgan Chase & Co. (JPM)
Facebook Inc cl a (META)
Lam Research (LRCX)
iShares S&P 500 Index (IVV)
Chevron Corporation (CVX)
Alphabet Inc Class C cs (GOOG)
Wal-Mart Stores (WMT)
Johnson & Johnson (JNJ)
Visa (V)

View all positions for Ameriprise Financial

Top funds holding Tscan Therapeutics

Lynx1 Capital Management
BVF
Baker Bros. Advisors
Vanguard Group
Vanguard Capital Management
BlackRock
Millennium Management
Deer Management
Two Sigma Investments
Renaissance Technologies
Standard Life Aberdeen
Jacobs Levy Equity Management
DC Funds
Geode Capital Management
GSA Capital Partners

View all funds holding Tscan Therapeutics